Charles Schwab Investment Management »

Seres Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $604k 31k 19.24
2025-06-30 $388k 35k 11.11